Bianca Weinstock-Guttman
Bianca Weinstock-Guttman, MD
Bianca Weinstock-Guttman, MD, is professor of neurology at Jacobs School of Medicine and Biomedical Science, University of Buffalo, NY.USA She is the director of the Jacobs Multiple Sclerosis Center for Treatment and Research and the Pediatric Multiple Sclerosis Center of Excellence, UB Neurology. She also serves as executive director of the New York State Multiple Sclerosis Consortium.
Weinstock-Guttman received a medical degree from the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed an internship at Carmel Hospital, Haifa, Israel, and a neurology residency at Meir General Hospital, Tel Aviv University, Israel. She then served a neuroimmunology fellowship at the Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH.
Over the course of her career, Weinstock-Guttman has been involved in numerous pivotal clinical trials in MS. Currently, she is involved in several phase III studies and in investigator-initiated phase I and IV studies.
She has published more than 390 peer-reviewed articles, primarily in neurology and immunology journals. She is frequently invited as a guest lecturer at national and international conferences and has given several hundred poster presentations worldwide.
Weinstock-Guttman currently concentrates her research on:
• Improving outcome measures including patient reported outcomes for monitoring MS disease course
• identifying predictors of disease progression (genetic and environmental interactions)
• Aging and MS with primary interest on cognition
• Pediatric MS, with studies conducted as part of the US national pediatric MS network
• How MS therapies affect patients’ physical and cognitive status
• Wellness including rehabilitation, mindfulness and dietary intervention for patients with MS
Weinstock-Guttman’s research is funded by various agencies, including the National Multiple Sclerosis Society, National Institutes of Health, as well as pharmaceutical corporations.
She is a member of numerous professional societies, including the American Academy of Neurology (AAN) and the American Association for the Advancement of Science., CMSC
She serves on the Board of ACTRIMS and as a medical advisory member and grant review committee for the U.S. National Multiple Sclerosis Society.
Bianca Weinstock-Guttman, MD, is professor of neurology at Jacobs School of Medicine and Biomedical Science, University of Buffalo, NY.USA She is the director of the Jacobs Multiple Sclerosis Center for Treatment and Research and the Pediatric Multiple Sclerosis Center of Excellence, UB Neurology. She also serves as executive director of the New York State Multiple Sclerosis Consortium.
Weinstock-Guttman received a medical degree from the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed an internship at Carmel Hospital, Haifa, Israel, and a neurology residency at Meir General Hospital, Tel Aviv University, Israel. She then served a neuroimmunology fellowship at the Mellen Center for MS Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH.
Over the course of her career, Weinstock-Guttman has been involved in numerous pivotal clinical trials in MS. Currently, she is involved in several phase III studies and in investigator-initiated phase I and IV studies.
She has published more than 390 peer-reviewed articles, primarily in neurology and immunology journals. She is frequently invited as a guest lecturer at national and international conferences and has given several hundred poster presentations worldwide.
Weinstock-Guttman currently concentrates her research on:
• Improving outcome measures including patient reported outcomes for monitoring MS disease course
• identifying predictors of disease progression (genetic and environmental interactions)
• Aging and MS with primary interest on cognition
• Pediatric MS, with studies conducted as part of the US national pediatric MS network
• How MS therapies affect patients’ physical and cognitive status
• Wellness including rehabilitation, mindfulness and dietary intervention for patients with MS
Weinstock-Guttman’s research is funded by various agencies, including the National Multiple Sclerosis Society, National Institutes of Health, as well as pharmaceutical corporations.
She is a member of numerous professional societies, including the American Academy of Neurology (AAN) and the American Association for the Advancement of Science., CMSC
She serves on the Board of ACTRIMS and as a medical advisory member and grant review committee for the U.S. National Multiple Sclerosis Society.
